BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15975949)

  • 1. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis.
    Scarlato M; Previtali SC; Carpo M; Pareyson D; Briani C; Del Bo R; Nobile-Orazio E; Quattrini A; Comi GP
    Brain; 2005 Aug; 128(Pt 8):1911-20. PubMed ID: 15975949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study.
    Briani C; Dalla Torre C; Lessi F; Cavallaro T; Scarlato M; Ferrari S; Campagnolo M; Lucchetta M; Cabrini I; Morbin M; Lauria G; Adami F; Manfredi AA
    J Neuroimmunol; 2014 Dec; 277(1-2):189-92. PubMed ID: 25447599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between serum level of vascular endothelial growth factor and subfoveal choroidal thickness in patients with POEMS syndrome.
    Yokouchi H; Baba T; Misawa S; Sawai S; Beppu M; Kitahashi M; Oshitari T; Kuwabara S; Yamamoto S
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1641-6. PubMed ID: 25367833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of changes in serum level of VEGF and peripapillary retinal thickness in patients with POEMS syndrome.
    Yokouchi H; Baba T; Misawa S; Oshitari T; Kuwabara S; Yamamoto S
    Br J Ophthalmol; 2020 Jan; 104(1):33-38. PubMed ID: 30914422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Crow-Fukase syndrome and VEGF].
    Arimura K; Hashiguchi T; Watanabe O
    Brain Nerve; 2008 Jun; 60(6):611-9. PubMed ID: 18567356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
    Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
    BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
    Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
    Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
    Misawa S
    Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
    He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
    Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. POEMS syndrome: the matter-of-fact approach.
    Scarlato M; Previtali SC
    Curr Opin Neurol; 2011 Oct; 24(5):491-6. PubMed ID: 21677582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome.
    Yokouchi H; Baba T; Misawa S; Kitahashi M; Oshitari T; Kuwabara S; Yamamoto S
    Br J Ophthalmol; 2017 Jun; 101(6):786-790. PubMed ID: 27707692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin and Nerve Neovascularization in POEMS Syndrome: Insights From a Small Cohort.
    Guibert C; Richard L; Durand S; Maquin F; Demiot C; Vallat JM; Jaccard A; Magy L; Duchesne M
    J Neuropathol Exp Neurol; 2020 May; 79(5):542-550. PubMed ID: 32296845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome.
    Wang C; Huang XF; Cai QQ; Cao XX; Cai H; Zhou D; Li J
    Leuk Res; 2016 Nov; 50():78-84. PubMed ID: 27697660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome.
    Yokouchi H; Baba T; Misawa S; Sawai S; Kitahashi M; Oshitari T; Kuwabara S; Yamamoto S
    Br J Ophthalmol; 2016 Jul; 100(7):897-901. PubMed ID: 26504179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pachymeningeal involvement in POEMS syndrome: MRI and histopathological study.
    Briani C; Fedrigo M; Manara R; Castellani C; Zambello R; Citton V; Campagnolo M; Dalla Torre C; Lucchetta M; Orvieto E; Rotilio A; Marangoni S; Magi S; Pareyson D; Florio I; Pegoraro E; Thiene G; Battistin L; Adami F; Angelini A
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):33-7. PubMed ID: 21653206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
    Khouri J; Nakashima M; Wong S
    JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
    Gao Y; Zhang S; Yang L; Li J; Liu Y; Wang T
    Front Immunol; 2021; 12():681360. PubMed ID: 34025681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome.
    Kanai K; Sawai S; Sogawa K; Mori M; Misawa S; Shibuya K; Isose S; Fujimaki Y; Noto Y; Sekiguchi Y; Nasu S; Nakaseko C; Takano S; Yoshitomi H; Miyazaki M; Nomura F; Kuwabara S
    Neurology; 2012 Aug; 79(6):575-82. PubMed ID: 22843279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin.
    Terracciano C; Fiore S; Doldo E; Manzari V; Marfia GA; Bernardi G; Massa R; Albonici L
    Muscle Nerve; 2010 Sep; 42(3):445-8. PubMed ID: 20589895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.
    Ma L; Wang Y; Bo J; Han W; Wang Y; Zhang L; Wu X; Yu S; Liu R
    Clin Exp Immunol; 2016 Apr; 184(1):83-9. PubMed ID: 26660736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.